ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,048,000 | +36.6% | 151,002 | +0.2% | 0.00% | 0.0% |
| Q3 2016 | $767,000 | -15.0% | 150,639 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $902,000 | +3010.3% | 151,049 | +2287.4% | 0.00% | – |
| Q1 2016 | $29,000 | 0.0% | 6,327 | -3.1% | 0.00% | – |
| Q4 2015 | $29,000 | +45.0% | 6,529 | +3.3% | 0.00% | – |
| Q3 2015 | $20,000 | +5.3% | 6,318 | 0.0% | 0.00% | – |
| Q2 2015 | $19,000 | -93.8% | 6,318 | -93.9% | 0.00% | – |
| Q1 2015 | $306,000 | -30.9% | 103,590 | +3.9% | 0.00% | -100.0% |
| Q4 2014 | $443,000 | -13.3% | 99,745 | +0.5% | 0.00% | 0.0% |
| Q3 2014 | $511,000 | +0.2% | 99,281 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $510,000 | – | 97,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |